We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 17, 2022

Empagliflozin for HFpEF in Patients With and Without Diabetes



Additional Info

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
Circulation 2022 Jun 28;[EPub Ahead of Print], G Filippatos, J Butler, D Farmakis, F Zannad, A Pernille Ofstad, J Pedro Ferreira, JB Green, J Rosenstock, S Schnaidt, M Brueckmann, SJ Pocock, M Packer, SD Anker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading